In response to the Prime Minister’s announcement on making Britain the go-to place for innovators and investors, Aisling Burnand, Chief Executive of AMRC (Association of Medical Research Charities) said:
“AMRC welcomes the Prime Minister’s ambition to make the UK the “global go-to place” for scientists and innovators, including the review of current R&D tax incentives and announcement of a new Industrial Strategy Challenge Fund. Investment in R&D is not only crucial for the UK economy, but for the NHS, patients and their families. By investing in research we are unlocking our understanding of health and furthering the discovering of new medical treatments and breakthroughs.
“Medical research charities play a significant role in UK R&D. We are calling on Government to ensure that charities are included in initiatives to boost investment in R&D. Last year, medical research charities invested £1.4bn in medical research and funded the salaries of 15,000 researchers. Over the last 8 years, charities have invested nearly £10bn in research in the UK.
“We urge Government to unleash the full potential of medical research charity investment as part of new Industrial Strategy. Ensuring that medical research charities, like businesses, are able to amplify their R&D spending.”